Thu 21'st Sep 2017
Rennova Health Stock Analysis
Technical stock analysis for Thu 21'st Sep 2017
Sell candidate since 2017-09-20 Loss -3.91%
Rennova Health lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.65% during the next 3 months and, with 90% probability hold a price between $0.10 and $0.15 at the end of this period.
There are few to none technical positive signals at the moment. Rennova Health holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.23 and $0.26. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday September 13, 2017, which indicates further falls until a new bottom pivot has been found. Rennova Health gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 20 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days. On the upside the stock meets some resistance from accumulated volume at $0.24, $0.25 and $0.26.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 11.50%. For the last week, the stock has had a daily average volatility of 8.19%.
Rennova Health is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Rennova Health holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
Trade RNVA CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service. Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).